Artificial Intelligence in Prostate Cancer Diagnosis on Magnetic Resonance Imaging: Time for a New PARADIGM.
Authors
Ng AB,Giganti F,Kasivisvanathan V
Affiliations (3)
Affiliations (3)
- Division of Surgery and Interventional Science, University College London, London, UK; Centre for Urology Imaging, Prostate, AI and Surgical Studies (COMPASS) Research Group, University College London, London, UK.
- Division of Surgery and Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
- Division of Surgery and Interventional Science, University College London, London, UK; Centre for Urology Imaging, Prostate, AI and Surgical Studies (COMPASS) Research Group, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: [email protected].
Abstract
Artificial intelligence (AI) may provide a solution for improving access to expert, timely, and accurate magnetic resonance imaging (MRI) interpretation. The PARADIGM trial will provide level 1 evidence on the role of AI in the diagnosis of prostate cancer on MRI.
Topics
Prostatic NeoplasmsArtificial IntelligenceMagnetic Resonance ImagingEditorial